BACKGROUND: Patients with pancreas divisum may develop pancreatitis. Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard for diagnosing pancreas divisum. Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive test reported to be highly accurate in diagnosing pancreas divisum. AIM: To evaluate the diagnostic accuracy of MRCP in detecting pancreas divisum at our institution. METHODS: We reviewed patients who underwent both ERCP and MRCP. Patients who had diagnostic endoscopic pancreatograms (ERP) after MRCP comprise the study population. Secretin was given in 113/146 patients (S-MRCP). The remaining 33/146 patients had MRCP without secretin. In 7/33 patients who underwent MRCP without secretin (21.2%), the studies were non-diagnostic and, therefore, this group was not further analyzed and the study focused on the S-MRCP group only. RESULTS: ERP identified pancreas divisum in 19/113 (16.8%) patients. S-MRCP identified 14/19 pancreas divisum and was false-positive in three cases (sensitivity 73.3%, specificity 96.8%, positive predictive value 82.4%, negative predictive value 94.8%). Of the eight patients with inaccurate S-MRCP, 5 (63%) had changes of chronic pancreatitis by ERP. This differs from the frequency of chronic pancreatitis by ERP in 24/105 (23%) patients with accurate MRCP findings. The ERCP findings of chronic pancreatitis were more frequent among incorrect S-MRCP interpretations than among correct interpretations (odds ratio [OR] 5.5 [95% confidence interval (CI) 1.3-25.3]). MRCP without secretin is non-diagnostic for pancreas divisum in a significant proportion of patients. S-MRCP had a satisfactory specificity for detecting pancreas divisum. However, the sensitivity of S-MRCP for the diagnosis of pancreas divisum was modest at 73.3%. This is low compared to previous smaller studies, which reported a sensitivity of MRCP of up to 100%.
BACKGROUND:Patients with pancreas divisum may develop pancreatitis. Endoscopic retrograde cholangiopancreatography (ERCP) is the gold standard for diagnosing pancreas divisum. Magnetic resonance cholangiopancreatography (MRCP) is a non-invasive test reported to be highly accurate in diagnosing pancreas divisum. AIM: To evaluate the diagnostic accuracy of MRCP in detecting pancreas divisum at our institution. METHODS: We reviewed patients who underwent both ERCP and MRCP. Patients who had diagnostic endoscopic pancreatograms (ERP) after MRCP comprise the study population. Secretin was given in 113/146 patients (S-MRCP). The remaining 33/146 patients had MRCP without secretin. In 7/33 patients who underwent MRCP without secretin (21.2%), the studies were non-diagnostic and, therefore, this group was not further analyzed and the study focused on the S-MRCP group only. RESULTS: ERP identified pancreas divisum in 19/113 (16.8%) patients. S-MRCP identified 14/19 pancreas divisum and was false-positive in three cases (sensitivity 73.3%, specificity 96.8%, positive predictive value 82.4%, negative predictive value 94.8%). Of the eight patients with inaccurate S-MRCP, 5 (63%) had changes of chronic pancreatitis by ERP. This differs from the frequency of chronic pancreatitis by ERP in 24/105 (23%) patients with accurate MRCP findings. The ERCP findings of chronic pancreatitis were more frequent among incorrect S-MRCP interpretations than among correct interpretations (odds ratio [OR] 5.5 [95% confidence interval (CI) 1.3-25.3]). MRCP without secretin is non-diagnostic for pancreas divisum in a significant proportion of patients. S-MRCP had a satisfactory specificity for detecting pancreas divisum. However, the sensitivity of S-MRCP for the diagnosis of pancreas divisum was modest at 73.3%. This is low compared to previous smaller studies, which reported a sensitivity of MRCP of up to 100%.
Authors: Andrew C F Taylor; Andrew F Little; Oliver F Hennessy; Simon W Banting; Peter J Smith; Paul V Desmond Journal: Gastrointest Endosc Date: 2002-01 Impact factor: 9.427
Authors: J M Scheiman; R C Carlos; J L Barnett; G H Elta; T T Nostrant; W D Chey; I R Francis; P S Nandi Journal: Am J Gastroenterol Date: 2001-10 Impact factor: 10.864
Authors: D H Park; M H Kim; S S Lee; S K Lee; K P Kim; J M Han; S Y Kim; M H Song; D W Seo; A Y Kim; T K Kim; Y I Min Journal: Endoscopy Date: 2004-11 Impact factor: 10.093
Authors: Darren D Ballard; Joyce R Flueckiger; Evan L Fogel; Lee McHenry; Glen A Lehman; James L Watkins; Stuart Sherman; Gregory A Coté Journal: Pancreas Date: 2015-01 Impact factor: 3.327
Authors: Robin Bülow; Peter Simon; Robert Thiel; Patrick Thamm; Philip Messner; Markus M Lerch; Julia Mayerle; Henry Völzke; Norbert Hosten; Jens-Peter Kühn Journal: Eur Radiol Date: 2014-08-15 Impact factor: 5.315
Authors: Vladimir M Kushnir; Sachin B Wani; Kathryn Fowler; Christine Menias; Rakesh Varma; Vamsi Narra; Christine Hovis; Faris M Murad; Daniel K Mullady; Sreenivasa S Jonnalagadda; Dayna S Early; Steven A Edmundowicz; Riad R Azar Journal: Pancreas Date: 2013-04 Impact factor: 3.327